Massachusetts Institute of Technology-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Massachusetts Institute of Technology-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH79111D
  • |
  • Pages: 61
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Massachusetts Institute of Technology (MIT) is a research university that provides contract research and education. The institute offers education in the areas of computer science, biology, aeronautics, mechanical engineering, civil engineering, economics, electrical engineering, literature, architecture, chemistry, mathematics, political science, history, linguistics, nuclear science, physics, and music and theater arts. It conducts research in the fields of neuroscience, humanities, anthropology, cancer, astronomy, oceanography, nuclear science, cognitive science, nanoscience, and nanotechnology. MIT provides services to its students like student information system, academic calendar, libraries, freshman advising, and student disabilities services. The institute offers extracurricular activities like sports, music, dance, arts, and athletics. MIT is headquartered, Cambridge, Massachusetts, the US.

Massachusetts Institute of Technology-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Massachusetts Institute of Technology, Medical Devices Deals, 2011 to YTD 2017 10

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 13

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 13

White Head Institute And Biogen Idec Enter Into Reasearch Agreement 14

Licensing Agreements 15

Cognito Therapeutics Enters into Licensing Agreement with Massachusetts Institute of Technology 15

Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School 16

Visterra Enters into Licensing Agreement with MIT for Dengue Virus Antibodies 17

Enumeral Biomedical Amends Licensing Agreement with Massachusetts Institute of Technology 18

Columbia Labs Enters into Licensing Agreement for IVR Technology 18

Gensight Biologics Enters into Option Agreement with Massachusetts Institute of Technology 19

MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 20

Syros Pharma Enters into Licensing Agreement with Whitehead Institute 22

Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 23

Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 24

Pervasis Therapeutics Enters Into Licensing Agreement With Massachusetts Institute 25

Massachusetts Institute of Technology-Key Competitors 27

Key Employees 28

Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Government and Public Interest 30

Mar 20, 2017: Tethered nanoparticles make tumor cells more vulnerable 30

Feb 10, 2017: U.S. Scientists Receive Inaugural $87 Million Grand Challenge Awards To Accelerate Global Progress To Beat Cancer Sooner 32

Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 33

Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 35

Aug 15, 2016: New enzyme-mapping advance could help drug development 37

Jul 04, 2016: Engineers design programmable RNA vaccines 39

Jun 08, 2016: Drug candidate shrinks tumor when delivered by plant virus nanoparticle 41

May 02, 2016: New drug-delivery approach holds potential for treating obesity 43

Apr 21, 2016: Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer 45

Feb 01, 2016: Curing disease by repairing faulty genes : Massachusetts Institute of Technology 46

Jan 25, 2016: Researchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months 48

Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 49

Jan 06, 2016: In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues 51

Product News 53

Nov 16, 2016: Next-generation biomaterial being developed to treat bleeding 53

May 02, 2016: Massachusetts Institute of Technology: Fat-fighting nanoparticles 54

Apr 18, 2017: Long-lasting drug delivery system may help decrease the spread of malaria 56

Apr 06, 2016: Engineers develop a pill for long-term drug release 57

Feb 27, 2017: New technology offers fast peptide synthesis 59

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61

List of Figures

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Massachusetts Institute of Technology, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Key Facts 1

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Massachusetts Institute of Technology, Deals By Therapy Area, 2011 to YTD 2017 9

Massachusetts Institute of Technology, Medical Devices Deals, 2011 to YTD 2017 10

Massachusetts Institute of Technology, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

CureMeta Enters into Research Agreement with Whitehead Institute for Biomedical Research 13

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 13

White Head Institute And Biogen Idec Enter Into Reasearch Agreement 14

Cognito Therapeutics Enters into Licensing Agreement with Massachusetts Institute of Technology 15

Frequency Therapeutics Receives Intellectual Property Rights from MIT and Harvard Medical School 16

Visterra Enters into Licensing Agreement with MIT for Dengue Virus Antibodies 17

Enumeral Biomedical Amends Licensing Agreement with Massachusetts Institute of Technology 18

Columbia Labs Enters into Licensing Agreement for IVR Technology 18

Gensight Biologics Enters into Option Agreement with Massachusetts Institute of Technology 19

MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 20

Syros Pharma Enters into Licensing Agreement with Whitehead Institute 22

Syros Pharma Enters into Licensing Agreement with Dana-Farber and Whitehead 23

Reflexion Pharma Enters into Licensing Agreement with Whitehead Institute for Biomedical Research 24

Pervasis Therapeutics Enters Into Licensing Agreement With Massachusetts Institute 25

Massachusetts Institute of Technology, Key Competitors 27

Massachusetts Institute of Technology, Key Employees 28

Massachusetts Institute of Technology, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Massachusetts Institute of Technology, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16145
Site License
USD 500 INR 32290
Corporate User License
USD 750 INR 48435

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com